- Home
- SST vs NVNO Comparison
SST vs NVNO Comparison
Compare SST & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SST
- NVNO
- Stock Information
- Founded
- SST 2013
- NVNO 1987
- Country
- SST United States
- NVNO United States
- Employees
- SST N/A
- NVNO N/A
- Industry
- SST Diversified Commercial Services
- NVNO Medical/Dental Instruments
- Sector
- SST Consumer Discretionary
- NVNO Health Care
- Exchange
- SST Nasdaq
- NVNO Nasdaq
- Market Cap
- SST 73.0M
- NVNO 59.4M
- IPO Year
- SST N/A
- NVNO N/A
- Fundamental
- Price
- SST $0.97
- NVNO $3.28
- Analyst Decision
- SST Hold
- NVNO
- Analyst Count
- SST 1
- NVNO 0
- Target Price
- SST $2.00
- NVNO N/A
- AVG Volume (30 Days)
- SST 110.9K
- NVNO 96.4K
- Earning Date
- SST 11-07-2024
- NVNO 10-31-2024
- Dividend Yield
- SST N/A
- NVNO N/A
- EPS Growth
- SST N/A
- NVNO N/A
- EPS
- SST N/A
- NVNO N/A
- Revenue
- SST $364,450,000.00
- NVNO N/A
- Revenue This Year
- SST N/A
- NVNO N/A
- Revenue Next Year
- SST $15.17
- NVNO N/A
- P/E Ratio
- SST N/A
- NVNO N/A
- Revenue Growth
- SST N/A
- NVNO N/A
- 52 Week Low
- SST $0.91
- NVNO $3.01
- 52 Week High
- SST $3.02
- NVNO $6.97
- Technical
- Relative Strength Index (RSI)
- SST 40.08
- NVNO 39.99
- Support Level
- SST $1.03
- NVNO $3.25
- Resistance Level
- SST $1.17
- NVNO $3.68
- Average True Range (ATR)
- SST 0.08
- NVNO 0.15
- MACD
- SST 0.00
- NVNO 0.03
- Stochastic Oscillator
- SST 19.96
- NVNO 9.20
About SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It serves customers in the areas of health and wellness, automotive, finance, travel, and entertainment. The company's segment includes Owned and Operated Advertising (O&O); and Partner Network. It generates maximum revenue from the Owned and Operated Advertising (O&O) segment.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).